BTN yields 77.52% · JNJ yields 2.14%● Live data
📍 BTN pulled ahead of the other in Year 1
Combined, BTN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BTN + JNJ for your $10,000?
Ballantyne Strong, Inc. operates in the entertainment industry worldwide. The company manufactures and distributes projection screens and customized screen support systems directly, as well as through third-party distributors and integrators. It also distributes other products and provides technical support services to the cinema exhibition industry, theme parks, schools, museums, and other entertainment-related markets. In addition, the company offers technical services, such as digital projection equipment installation, and after-sale maintenance and network support services directly to theater owners and other entertainment-related markets, as well as through dealers or value added reseller networks. Further, it distributes and supports third party products, including digital projectors, servers, library management systems, menu boards, and sound systems; and operates digital ignition technology incubator and co-working facility in Alpharetta, Georgia. Ballantyne Strong, Inc. was founded in 1932 and is based in Charlotte, North Carolina.
Full BTN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.